WUSTL
   

"All health care providers and office personnel are extremely caring and helpful. It makes a big difference when you have a serious disease."

Gynecologic Oncology
 : 
Research Publications

  • Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, Schmidt AP, Feng S, Hampel HL, Chapelle AD, Goodfellow PJ. Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer. 2007 Jan 17;
  • Buttin BM, Powell MA, Goodfellow PJ, Lewin SN, Gibb RK, Mutch DG.  Increased risk for abnormalities on perioperative colon screening in patients with microsatellite instability-positive endometrial carcinoma. Int J Gynecol Cancer. 2006 Nov-Dec;16(6):1980-6.
  • Shim TL, Wright JD, Rubin BG, Mutch DG.  A vascular graft for endometrial cancer groin recurrence. Gynecol Oncol. 2006 Dec 12.
  • Society of Gynecologic Oncologists Education Resource Panel Writing group; Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J.  Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol. 2006 Sep;102(3):552-62. Review.
  • Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW.  Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):480-4.
  • Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW.  Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat Med. 2006 Nov;24(9):625-30.
  • McCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA.  Body mass index: Relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.  Gynecol Oncol. 2006 Nov 13;
  • Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K; ASCO; SSO.  ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.  J Clin Oncol. 2006 Oct 1;24(28):4642-60.
  • Wang SS, Sherman ME, Rader JS, Carreon J, Schiffman M, Baker CC.  Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. Diagn Mol Pathol. 2006 Sep;15(3):144-8.
  • Taylor NP, Powell MA, Gibb RK, Rader JS, Huettner PC, Thibodeau SN, Mutch DG, Goodfellow PJ.  MLH3 mutation in endometrial cancer.  Cancer Res. 2006 Aug 1;66(15):7502-8.
  • Baum ME, Rader JS, Gibb RK, McAlister RP, Powell MA, Mutch DG, Gao F, Wright JD.   Colposcopic accuracy of obstetrics and gynecology residents.  Gynecol Oncol. 2006 Dec;103(3):966-70. Epub 2006 Jul 27.
  • Herzog TJ, Powell MA, Rader JS, Gibb R, Mutch DG.  Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.  Gynecol Oncol. 2006 Nov;103(2):637-41. Epub 2006 Jun 15.
  • Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA.  Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.  Cancer. 2006 Jul 1;107(1):83-9.
  • Gossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ.  CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan. Gynecol Oncol. 2006 Oct;103(1):212-8.